Inspections, Compliance, Enforcement, and Criminal Investigations
Lehigh Valley Technologies, Inc. - Close Out Letter 1/9/12
Department of Health and Human Services
|Public Health Service|
Food and Drug Administration
January 9, 2012
RETURN RECEIPT REQUESTED
Mr. Jeffrey M. Moshal, President and CEO
Lehigh Valley Technologies Inc.
513 N. 12th Street
Allentown, PA 18102
Dear Mr. Moshal:
The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter 11-PHI-17, dated July 15, 2011. Based on our evaluation, it appears that you have addressed the violation(s) contained in the Warning Letter. Future FDA ·inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or you firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and it implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.